Atara Biotherapeutics Inc

NASDAQ:ATRA   3:59:57 PM EDT
19.54
+0.22 (+1.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Atara Biotherapeutics, Inc. Stock, NASDAQ:ATRA

611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO, CA 94080
United States of America
Phone: 650-278-8930
Number of Employees: 311

Description

Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of muscle wasting conditions and oncology. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. The company is also developing STM 434, a targeted therapy for ovarian cancer and other solid tumors; and a pipeline of product candidates that are in preclinical development. Atara Biotherapeutics, Inc. was founded in 2012 and is headquartered in Brisbane, California.